Aurinia Pharmaceuticals Inc. (AUPH)

Aurinia Pharmaceuticals Revenue

Aurinia Pharmaceuticals had revenue of $77.71M in the quarter ending March 31, 2026, with 24.40% growth. This brings the company's revenue in the last twelve months to $298.30M, up 20.62% year-over-year. In the year 2025, Aurinia Pharmaceuticals had annual revenue of $283.06M with 20.38% growth.

• Revenue (ttm): $298.30M
• Revenue Growth: +20.62%
• P/S Ratio: 6.83
• Revenue / Employee: $2,330,430
• Employees: 128
• Market Cap: 2.04B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	283.06M	47.92M	20.38%
Dec 31, 2024	235.13M	59.62M	33.97%
Dec 31, 2023	175.51M	41.48M	30.95%
Dec 31, 2022	134.03M	88.43M	193.89%
Dec 31, 2021	45.61M	-4.51M	-9.00%
Dec 31, 2020	50.12M	49.80M	15,660.38%
Dec 31, 2019	318.00K	-145.00K	-31.32%
Dec 31, 2018	463.00K	45.00K	10.77%
Dec 31, 2017	418.00K	245.00K	141.62%
Dec 31, 2016	173.00K	-1.00M	-85.29%
Dec 31, 2005	1.18M	-	-

Data Source: Fiscal.ai Last updated: May 7, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 5, 2026

Data Sources Report a data error